BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17185074)

  • 1. EMR for intramucosal adenocarcinoma of the esophagus: does one size fit all?
    DeMeester SR
    Gastrointest Endosc; 2007 Jan; 65(1):14-5. PubMed ID: 17185074
    [No Abstract]   [Full Text] [Related]  

  • 2. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
    Lewis JT; Wang KK; Abraham SC
    Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic resection for treatment of mucosal Barrett's cancer: time to swing the pendulum.
    Bergman JJ
    Gastrointest Endosc; 2007 Jan; 65(1):11-3. PubMed ID: 17185073
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia.
    Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY
    Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
    Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
    Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic management of esophageal malignancy: lessons learned from gastric cancer.
    Brugge WR
    Curr Opin Gastroenterol; 2006 Sep; 22(5):527-8. PubMed ID: 16891884
    [No Abstract]   [Full Text] [Related]  

  • 11. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
    Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
    Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic mucosal resection and mucosa ablation with argon-plasma coagulation in a high-risk patient with Barrett's oesophagus and oesophageal adenocarcinoma.
    Lorenzo-Zúñiga V; Boix J
    Dig Liver Dis; 2006 Sep; 38(9):713-4. PubMed ID: 16787771
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical images in gastroenterology. Barrett esophagus of distinctive type and adenocarcinoma].
    Barinagarrementeria Aldatz R; Güitrón Cantú JA
    Rev Gastroenterol Mex; 1997; 62(1):58. PubMed ID: 9190656
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of endoscopic treatment of early Barrett neoplasia: the endoscopist's view.
    Falk GW
    Endoscopy; 2008 Dec; 40(12):1041-7. PubMed ID: 19065489
    [No Abstract]   [Full Text] [Related]  

  • 15. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
    Peyre CG; DeMeester SR; Rizzetto C; Bansal N; Tang AL; Ayazi S; Leers JM; Lipham JC; Hagen JA; DeMeester TR
    Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic submucosal dissection of a minute intramucosal adenocarcinoma in Barrett's esophagus.
    Ikeda K; Isomoto H; Oda H; Shikuwa S; Mizuta Y; Iwasaki K; Kohno S
    Dig Endosc; 2009 Jan; 21(1):34-6. PubMed ID: 19691799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where the twains should meet.
    Reed CE
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1183-4. PubMed ID: 18829394
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgery or ablation therapy for HGD in patients with Barrett's esophagus?
    Eloubeidi MA
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1180. PubMed ID: 18854228
    [No Abstract]   [Full Text] [Related]  

  • 19. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?
    Sharma P; Wani S; Rastogi A
    Gastrointest Endosc; 2007 Sep; 66(3):469-74. PubMed ID: 17725936
    [No Abstract]   [Full Text] [Related]  

  • 20. Selecting treatment for Barrett's esophagus: no second chances to make a first impression.
    Wang KK
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1181-2. PubMed ID: 18995212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.